Stock Research: Dexcom

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Dexcom

NasdaqGS:DXCM US2521311074
52
  • Value
    53
  • Growth
    41
  • Safety
    Safety
    22
  • Combined
    22
  • Sentiment
    82
  • 360° View
    360° View
    52
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

DexCom, Inc. is a medical device company focused on continuous glucose monitoring systems. The company operates in the medical device industry and its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The company enables people to take control of health through innovative biosensing technology. In the last fiscal year, the company had a market cap of $33,519 million, profits of $2,492 million, revenue of $4,033 million, and 10300 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 52 (better than 52% compared with alternatives), overall professional sentiment and financial characteristics for the stock Dexcom are above average. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Dexcom. The consolidated Sentiment Rank has a good rank of 82, which means that professional investors are more optimistic about the stock than for 82% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 53 or better than 53% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 22, meaning that the share price of Dexcom is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 41. ...read more

more
Index
NASDAQ 100
NASDAQ
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Nov-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 9 4 5
Growth
41 65 87 45
Safety
Safety
53 39 29 29
Sentiment
82 82 89 100
360° View
360° View
52 42 67 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
93 95 95 79
Opinions Change
76 52 63 67
Pro Holdings
n/a 88 98 94
Market Pulse
34 37 47 67
Sentiment
82 82 89 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 9 4 5
Growth
41 65 87 45
Safety Safety
53 39 29 29
Combined
22 19 27 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
46 14 10 20
Price vs. Earnings (P/E)
34 17 5 6
Price vs. Book (P/B)
25 20 12 14
Dividend Yield
1 1 1 1
Value
22 9 4 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
68 73 75 67
Profit Growth
66 76 94 34
Capital Growth
10 51 34 9
Stock Returns
39 27 67 91
Growth
41 65 87 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
26 20 22 25
Refinancing
27 14 17 25
Liquidity
87 97 90 67
Safety Safety
53 39 29 29

Similar Stocks

Discover high‑ranked alternatives to Dexcom and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.